Zymeworks (ZYME) Cash from Financing Activities (2021 - 2026)

Zymeworks has reported Cash from Financing Activities for 6 years, with the latest figure at $178.8 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 13485.56% year-over-year to $178.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158.9 million (up 847.78% YoY) and the FY2025 annual result came in at -$18.6 million, up 9.19% from the prior year.
• Cash from Financing Activities improved to $178.8 million in Q1 2026 per ZYME's latest filing, from -$18.7 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $178.8 million in Q1 2026 and troughed at -$18.7 million in Q4 2025.
• A 5-year average of $19.4 million and a median of $1.3 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 13530.24% in 2023, then slumped 889.87% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$377000.0 in 2022, then jumped by 13530.24% to $50.6 million in 2023, then sank by 117.07% to -$8.6 million in 2024, then tumbled by 116.87% to -$18.7 million in 2025, then surged by 1053.93% to $178.8 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $178.8 million, -$18.7 million, and -$2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.